Cidara Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
Cidara Therapeutics is registering the resale of 7,041,309 shares of its common stock by selling stockholders after a recent private placement.
Cidara Therapeutics is registering for resale up to 16.8 million shares of its common stock by selling stockholders following a private placement of Series A Preferred Stock.